Literature DB >> 16857575

Psychogenic movement disorders.

Vanessa K Hinson1, W Blake Haren.   

Abstract

Diagnosis and treatment of psychogenic movement disorders are challenging for both neurologists and psychiatrists. Symptoms can mimic the full range of organic abnormal involuntary movements, affect gait and speech, or present as unusual undifferentiated movements. Typical clinical characteristics of these disorders are acute onset, fast progression, movement patterns incongruent with organic movement disorders, distractibility, variability, and simultaneous occurrence of various abnormal movements and dysfunctions. Avoidance of iatrogenic damage by unnecessary invasive tests or inappropriate medication, as well as use of appropriate psychiatric treatments are pivotal steps in the management of these disorders. The few clinical trials specific to psychogenic movement disorders focus on antidepressants and psychotherapy. Presence of a comorbid psychiatric diagnosis of depression or an anxiety disorder is a positive prognostic factor, whereas long-standing symptoms, insidious onset of movements, and a psychiatric diagnosis of hypochondriasis, factitious disorder, or malingering are associated with poor outcome.

Entities:  

Mesh:

Year:  2006        PMID: 16857575     DOI: 10.1016/S1474-4422(06)70523-3

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  20 in total

Review 1.  Physiology of psychogenic movement disorders.

Authors:  Mark Hallett
Journal:  J Clin Neurosci       Date:  2010-05-20       Impact factor: 1.961

2.  Psychogenic movement disorders.

Authors:  Elizabeth L Peckham; Mark Hallett
Journal:  Neurol Clin       Date:  2009-08       Impact factor: 3.806

3.  A 2-Year-Old Girl with Functional Dystonia Manifesting as Forceful Finger Flexion Producing Fixed Posture of Clenched Hands.

Authors:  Debabrata Ghosh
Journal:  Mov Disord Clin Pract       Date:  2017-09-19

Review 4.  Opinion: A role for placebo therapy in psychogenic movement disorders.

Authors:  Karen S Rommelfanger
Journal:  Nat Rev Neurol       Date:  2013-04-30       Impact factor: 42.937

5.  [Differential diagnosis of epileptic seizures].

Authors:  J Rémi; S Noachtar
Journal:  Nervenarzt       Date:  2012-02       Impact factor: 1.214

6.  Gelsolin in cerebrospinal fluid as a potential biomarker of epilepsy.

Authors:  Xi Peng; Xiaogang Zhang; Liang Wang; Qiong Zhu; Jing Luo; Wei Wang; Xuefeng Wang
Journal:  Neurochem Res       Date:  2011-07-24       Impact factor: 3.996

Review 7.  Psychogenic movement disorders.

Authors:  Francesca Morgante; Mark J Edwards; Alberto J Espay
Journal:  Continuum (Minneap Minn)       Date:  2013-10

8.  Sensitivity and specificity of the finger tapping task for the detection of psychogenic movement disorders.

Authors:  Susan Criswell; Callen Sterling; Laura Swisher; Brad Evanoff; Brad A Racette
Journal:  Parkinsonism Relat Disord       Date:  2009-12-14       Impact factor: 4.891

Review 9.  Functional Movement Disorders and Placebo: A Brief Review of the Placebo Effect in Movement Disorders and Ethical Considerations for Placebo Therapy.

Authors:  Bonnie M Kaas; Casey Jo Humbyrd; Alexander Pantelyat
Journal:  Mov Disord Clin Pract       Date:  2018-10-09

10.  Functional Speech and Voice Disorders: Case Series and Literature Review.

Authors:  David S Chung; Chelsea Wettroth; Mark Hallett; Carine W Maurer
Journal:  Mov Disord Clin Pract       Date:  2018-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.